https://sciencedaily.com/releases/2021/09/210907110650.htm
Four independent studies show rovalpituzumab tesirine ineffective against small cell lung cancer |...
Four independent studies demonstrate that rovalpituzumab tesirine for small-cell lung cancer (SCLC) is not effective against SCLC, casting a pall over the...
independent studies
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2021-12482&r=1
Loncastuximab Tesirine in Combination with Rituximab for the Treatment of Relapsed/Refractory...
Loncastuximab Tesirine in Combination with Rituximab for the Treatment of Relapsed/Refractory Follicular Lymphoma